• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Norway

Community Funding News

We have assembled a list of community-based funding opportunities available via various NIDDK-supported centers, e.g.,  pilot projects, training opportunities.   To view this list in a table, please check out dkNET Pilot Funding News: List. For a list of funding opportunities available from US government agencies, please search our Funding Opportunities database.

  • Mid-Atlantic Nutrition Obesity Research Center Pilot & Feasibility Program
    End: May 13, 2019

    The aim of a P/F project is to provide convincing data for future proposals to the NIH or other national agencies. Investigators are encouraged to undertake high risk/high gain projects that have the potential to develop but for which no preliminary data of feasibility are currently available. Nevertheless, the capability of the PI (and his/her collaborators) to undertake such a project should be clearly outlined. P/F projects are strongly encouraged to take advantage of our Core laboratories. These are: 1) Administrative Core, including Biostatistics and Medical Informatics (BMI) Subcore; 2) Clinical and Translational Research (CTR) Core; 3) Biological Mechanisms and Functional Genomics (BMFG) Core; and 4) Molecular Genetics and Nutrigenomics (MGN) Core. Information on these cores can be found at our web site: http://medschool.umaryland.edu/norc/cores.asp. All applicants must be willing to actively participate in Mid-Atlantic NORC Center activities, including seminars, workshops, and symposia, and to present NORC seminars describing their work. Each P/F awardee will be assigned a working group and must be willing to meet regularly with the working group (2-4 times per year, depending on progress). Letter of Intent due by March 4, 2019. Applicants for these awards must be faculty at an academic institution affiliated with the Mid-Atlantic NORC.

    Program: Mid-Atlantic Nutrition Obesity Research Center

    Award Amount: up to $50,000

    Duration: 1 year

  • DiaComp Pilot and Feasibility Program
    Start: January 12, 2017      End: June 10, 2019

    This program solicits and funds small Pilot and Feasibility (P&F) projects in high impact areas of complications research. Specifically, this program aims to support discovery (hypothesis generating) and innovative (high risk/ high reward) research that is increasingly difficult to support through standard NIH mechanisms. Basic, translational and clinical research proposals are encouraged. Research involving human subjects is limited to observational studies with non-invasive or minimally invasive testing and must have IRB approval that includes the collection and use of human samples for research purposes. Interventional clinical trials are beyond the scope of this program. Awards are expected to prepare the applicant(s) to submit a future investigator initiated project (e.g. NIH R01). Lower priority will be given to applicants who have received DiaComp support in the past three years.

    Program: DiaComp

    Award Amount: $100,000

    Duration: 1 Year

  • Baylor College of Medicine Pilot and Feasibility Program

    Program: Baylor College of Medicine

    Award Amount: Up to $50,000

    Duration: 1-2 years

  • Nuclear Receptors and Gut Microbiome
    Start: January 1, 2013      End: December 31, 2013

    It has become increasingly well-appreciated that the gut microbiome plays an integral role in the course of metabolic disease. Proposals for this topic investigate the role of NRs and NR signaling in mediating effects of the gut microbiome on intestinal physiology, barrier function, and inflammation. Integrate metagenomics, microbial metabolomics, gnotobiotic, and/or transgenic approaches to identify specific bacterial factors that act via nuclear receptors in the intestine and/or define NR-dependent changes in intestinal function due to alterations in the gut microbiome.

    Program: NURSA

    Award Amount: $150,000

  • Nuclear Receptors in ENCODE
    Start: June 1, 2013      End: December 31, 2013

    Nuclear receptors and their co-associated proteins regulate gene expression in a tissue, cell, ligand and time specific manner. NRs bind to DNA in the context of chromatin patterns and cell specific gene regulation is mediated through the use of different combinations of epigenetic features. The ENCODE project has assigned biochemical function to 80% of the human genome and the publically available database provides a rich source of integrative data. Applications for this topic combined nuclear receptor expertise with bioinformatics expertise for mining the datasets available from ENCODE, thus allowing the elucidation of NR-specific signaling in a context that is relevant to metabolic or reproductive disease.

    Program: NURSA

    Award Amount: $150,000

    Duration: 1-2 years

  • Center for American Indian and Alaska Native Diabetes Translational Research Pilot Project
    Start: January 1, 2015      End: June 12, 2015

    Center for American Indian and Alaska Native Diabetes Translational Research's (CAIANDTR) Pilot and Feasibility Program supports small scale research projects that explore the extension of diabetes prevention and treatment research - with special emphasis on reducing risk as well as enhancing clinical outcomes - to American Indians and Alaska Natives. The CAIANDTR is particularly interested in stimulating work that considers the relevance of recent discoveries for application within Native communities. Toward this end, we will soon be soliciting a new round of proposals from University of Colorado Denver faculty.This funding opportunity provides two (2) years of support, at $25,000 per year, to either new investigators in the process of establishing careers in diabetes prevention and/or treatment research or mid-career scientists seeking to redirect their efforts to translational research consistent with our mission. Successful applicants will be expected to pursue the research in question among an American Indian or Alaska Native community for whom such work is of high priority. The CAIANDTR will assist investigators in establishing the academic/community partnerships necessary to undertake funded projects. The proposed study must be scientifically meritorious, be feasible within the time and resources available, hold promise of local benefit, and suggest a line of inquiry that can continue beyond the terms of this initial investment. University of Colorado Denver faculty are eligible to apply.

    Program: Center for American Indian and Alaska Native Diabetes Translational Research

    Award: $25,000

    Duration: 2 years

  • Center for Alaska Native Health Research (CANHR) Pilot Project Awards
    Start: May 1, 2015      End: June 29, 2015

    Awards are intended to foster the development of outstanding research scientists at the University of Alaska Fairbanks working in research that addresses health concerns of Alaska Native people. Awards are also designed to support activities that will lead to a new competitive research proposal for sustainable, external funding, as well as to sustainability of existing CANHR core resources (see http://canhr.uaf.edu/ for a full description of the CANHR cores). It is expected that a competitive external proposal will be submitted within one year of the completion of the pilot project grant. Eligibility: The project leader must be a full time UAF tenure track faculty, research faculty or research associate, and be willing to submit their follow-on research project grant through CANHR.

    Program: Center for Alaska Native Health Research

    Award Amount: $30,000 - $70,000

    Duration: 1 - 2 Years

  • University of North Carolina (UNC) Center for Diabetes Translation Research to Reduce Health Disparities Pilot Funding
    Start: June 1, 2015      End: July 20, 2015

    The goal of the program is to facilitate the success of Early Stage Investigators as they enter the field of diabetes translational research, with a focus on becoming independently funded diabetes researchers.The pilot and feasibility program also seeks to facilitate the success of more senior investigators as they change fields and enter the field of diabetes translational research.Each year, the CDTR will fund up to 3 awards, each for $20-40,000, for a period of one year. Eligibility: Primary Appointments from UNC-Chapel Hill or from our partnering institutions (examples inlcude UNC-Pembroke, East Carolina University, Wake Forest University, and Robeson County Health Department)

    Program: University of North Carolina (UNC) Center for Diabetes Translation Research

    Award Amount: $20,000 - $40,000

    Duration: One Year

  • BIOCADDIE Pilot Project on Harvester for DDI Schema
    Start: August 1, 2015      End: August 31, 2015

    The biomedical and healthCAre Data Discovery Index Ecosystem (bioCADDIE) consortium announces a call for proposals for a Pilot Project Grant on developing a metadata harvester for the data discovery index (DDI). bioCADDIE is part of the National Institutes of Health’s (NIH) Big Data to Knowledge (BD2K) program, which is committed to building a prototype of a DDI to facilitate the search for datasets by researchers and provide them information about data objects available in major data repositories or aggregators, their associations,  and access conditions. Eligibility: Applications may come from any organization where a subcontract to the University of California can be executed.  All software and algorithms funded in the Pilot Project have to be open source [Apache License 2.0].

    Program: The biomedical and healthCAre Data Discovery Index Ecosystem (bioCADDIE) consortium

    Award Amount: $50,000

    Duration: Six Months

  • NURSA Data Source Project (NDSP) RFPs
    End: September 1, 2015

    With this third NDSP announcement, we are soliciting applications that take an integrative physiology approach to address how nuclear receptor (NR) signaling mediates inter-tissue communication to regulate metabolic flow across multiple tissues (e.g. liver, adipose, gut, muscle). Many studies to date have investigated signaling and metabolic pathways at a tissue specific level. While these types of studies are clearly crucial to the understanding of metabolism in a specific cell or tissue type, we are looking for proposals that address the mechanisms by which tissues communicate with each other to regulate the homeostatic flow of nutrients. Numerous studies have demonstrated the integral role that NRs play in metabolic signaling; however, here we are challenging investigators to address the integrative physiology of NR signaling. As one of these projects will be funded by NICHD, your proposal could also address how inter-tissue NR signaling might impact reproduction. In both cases, we expect that these NDSPs would bring in new concepts and investigators to the NURSA Hub while leveraging the big data capabilities of the Hub with an influx of different data types. Funding Information: Total costs for each NDSP cannot exceed $150,000/year for 1-2 years. We expect to fund 3-4 NDSPs (for 1 year with additional years dependent on progress and availability of funds). Instructions: Letters of intent should be no more than one page in length and should be addressed to Dr. Neil McKenna no later than April 30th.

    Program: Nuclear Receptor Signaling Atlas

    Funding Amount: $150,000

    Duration: 1-2 Years

  • UCLA GeroNet
    Start: November 1, 2014      End: November 30, 2015

    The UCLA Claude D. Pepper Older Americans Independence Center (OAIC) and the UCLA Clinical and Translational Science Institute (CTSI) are soliciting applications for the Rapid Pilot Grants Program for aging-related basic, clinical and health services research. Award size will range from $1,000 to $10,000, dependent on scope of work. A "rolling applications process" will be used. Applications will be accepted until the allocated funds for this program have been spent. Eligibility: UCLA faculty only

    Eligibility: The UCLA Claude D. Pepper Older Americans Independence Center (OAIC); UCLA Clinical and Translational Science Institute (CTSI)

    Award Amount: $1000-$10,000

    Duration: Unknown

  • UCLA CHIPTS Pilot Program Domestic and international social and behavioral HIV research
    Start: September 20, 2015      End: December 12, 2015

    The Center for HIV, Identification, Prevention and Treatment Services (CHIPTS) is accepting pilot grant applications for domestic social, behavioral and policy research studies relevant to HIV/AIDS in Los Angeles County, from faculty investigators, postdoctoral fellows, and graduate students at CHIPTS affiliated institutions (i.e., UCLA and Friends Research Institute). A total of $90,000 is available to fund Investigator awards up to $30,000 and postdoctoral and graduate student awards up to $15,000. It is anticipated that three to four proposals will be funded. Eligibility: Applicants must have a full-time faculty or postdoctoral appointment at a CHIPTS institution (UCLA or Friends Research), or be enrolled in a graduate program at a CHIPTS institution.

    Program: UCLA CHIPTS

    Award Amount: $15,000 - $30,000

    Duration: One Year

  • UCLA Center for AIDS Research (CFAR)/AIDS Institute/ CHIPTS Domestic social and behavioral HIV research that includes biomarkers or other clinical interventions
    Start: November 20, 2015      End: December 12, 2015

    CHIPTS is also collaborating with the UCLA Center for AIDS Research (CFAR)/AIDS Institute to support a targeted call. Up to $20,000 is available for a domestic social and behavioral HIV research project that includes biomarkers. Research proposals could include biomarkers such as ARV levels or substance use in hair, nails, taggants, exhalants, or urine. Eligibility: Applicants must have a full-time faculty or postdoctoral appointment at a CHIPTS institution (UCLA or Friends Research), or be enrolled in a graduate program at a CHIPTS institution.

    Program: UCLA Center for AIDS Research (CFAR)/AIDS Institute; CHIPTS

    Award Amount: $20,000

    Duration: One Year

  • Diabetic Complications Consortium (DiaComp) Preclinical Testing Program
    Start: January 1, 2015      End: January 1, 2016

    APPLICATION NOTE: There is no formal deadline associated with Preclinical applications, but applications will be reviewed quarterly (March 1, June 1, September 1, December 1) and so should be submitted accordingly. PROGRAM DESCRIPTION: T1D-RAID and NIH-RAID are cooperative programs designed to facilitate translation to the clinic of novel, scientifically meritorious therapeutic interventions. However, in some cases, additional preclinical testing is needed to validate potential therapies under disease-specific conditions and in multiple animal models before new therapeutics can progress along the drug development pipeline.In recognition of the compelling need to develop new therapeutics for several diabetic complications, the DiaComp has established a Preclinical Testing Program (DiaComp-PTP). The DiaComp-PTP will provide investigators with access to pilot funds to pursue additional preclinical studies of promising new therapeutics. The T1D-RAID and DiaComp-PTP are programs intended to remove the most common barriers to progress in identification and development of new therapies for complications of Type 1 Diabetes. The common goal of these programs is to support the preclinical work necessary to obtain "proof of principle" establishing that a new molecule or novel approach will be a viable candidate for expanded clinical evaluation. Eligibility:  Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Young investigators are encouraged to apply.

    Program: Diabetic Complications Consortium

    Award Amount: $50,000 - $60,000

    Duration: 1 Year

  • University of Kansas Alzheimer's Disease Center Pilot Grant Program
    Start: December 6, 2015      End: March 4, 2016

    The KU Alzheimer's Disease Center and the Landon Center on Aging administer a competitive grant program to support innovative pilot studies relevant to Alzheimer's disease and brain aging. Up to three awards of $30,000 are funded annually.Proposals designed to generate preliminary data or publications that help the investigator successfully compete for extramural grants are encouraged. Early-stage investigators and those not currently performing AD research will be given special consideration, but established AD investigators are also eligible. Any faculty with a KUMC affiliation is eligible to apply. Postdoctoral fellows with eligible faculty mentors may also apply.LETTER OF INTENT DEADLINE – JANUARY 29, 2016. Eligibility: Any faculty with a KUMC affiliation is eligible to apply. Postdoctoral fellows with eligible faculty mentors may also apply.

    Program: University of Kansas Alzheimer's Disease Center

    Award Amount: $30,000

    Duration: One Year

  • Nuclear Receptor Signaling Atlas (NURSA) Hub Open Competition for NURSA Data Source Projects (NDSP)
    Start: May 1, 2016      End: June 24, 2016

    The nuclear receptor (NR) community has generated a large number of discovery-scale transcriptomic datasets that collectively document the tissue-specific regulation of gene expression by NR signaling pathways. Despite their potential for affording insight into unknown or unfamiliar NR signaling pathway biology, these datasets have been poorly exposed for re-use by the research community. In response to this, the NURSA Hub is aggregating, curating and processing these datasets to enhance their discoverability, accessibility and citability. The full current list of datasets can be browsed on the NURSA Dataset home page or the 30,000,000+ data points in the entire resource can be mined via the Transcriptomine search engine. To fully leverage this significant investment of knowledge and expertise, this fourth NDSP announcement solicits applications based on the existing collection of NURSA transcriptomic data points. Examples of responsive applications include: Demonstrating how the Transcriptomine knowledgebase can be leveraged to identify novel gene-tissue-NR signaling pathway relationships that have not been previously characterized in the published research literature, and that can be then validated in a bench research component. Development of data visualization and analysis tools that interface with Transcriptomine to extend its utility. Interoperability and/or integration between NURSA and external resources with complementary ‘omics-scale datasets, or biocuration activites to support such integration (e.g. integration of ChIP-Seq datasets).

    Program: NURSA

    Award Amount: $150,000

    Duration: 1-2 Years

  • Nuclear Receptor Signaling Atlas (NURSA) Hub Open Competition for NURSA Data Source Projects (NDSP)
    Start: October 19, 2016      End: November 20, 2016

    The mission of the Nuclear Receptor Signaling Atlas (NURSA) is to accrue, develop, and communicate information advancing our understanding of the integral role of nuclear receptor signaling in physiology and metabolic diseases, including diabetes, obesity, and reproductive diseases and disorders. Currently, the central core of NURSA is a Hub that provides the integration and cohesion needed to aggregate, annotate, and present state-of-the-art data in a user friendly fashion. A web portal, www.nursa.org, interfaces with the broader scientific community. To achieve its goals, the NURSA Informatics Hub solicits Project applications to support innovative research to the Hub. Successful PIs will leverage their individual and collaborative resources to address the scientific goals of this Request for Applications. Three previous similar announcements resulted in 11 NURSA-funded projects that support high quality cross-cutting research. The NR community has generated a large number of omics-scale datasets that collectively document functional endpoints of NR signaling pathways throughout the body. Despite their potential in elucidating NR signaling in health and disease, these datasets have yet to be leveraged to their full potential.  Accordingly, the NURSA Hub has invested considerable effort in aggregating, annotating, curating, and processing these datasets to enhance their use. The full current list of datasets can be browsed on the NURSA Dataset home page, or the resource’s 40,000,000+ data points can be mined via Transcriptomine. To fully capitalize on this significant investment of knowledge and expertise, this NDSP announcement solicits applications based on the following goals:(1)Extend Transcriptomine by building new visualization and analysis tools. (2) Leverage the Transcriptomine API to build web applications that will reach research communities beyond the nuclear receptor field. (3) Improve the scope of Transcriptomine through biocuration of complementary ‘omics-scale datasets. Successful applications will have a substantial informatics focus and relevance to the physiology and/or pathophysiology of metabolic disease. Unlike previous solicitations, and recognizing integrative cross-talk between different signaling paradigms, applications need not themselves relate specifically to nuclear receptor signaling. Where appropriate, applicants are encouraged to use the Transcriptomine application programming interface (API). Applications that propose active collaboration with the NURSA Informatics Hub are particularly welcome, and discussions with the NURSA Project Scientist Dr. Corinne Silva (silvacm@niddk.nih.gov) or the NURSA Project Leader Dr. Neil McKenna (nmckenna@bcm.edu) prior to submission of proposals are strongly encouraged. Deadline for letter of intent: November 7, 2016.     

    Program: NURSA

    Award Amount: $150,000

    Duration: 1 year

  • Immune Tolerance Network Clinical Trial Proposals
    Start: January 1, 2015      End: December 31, 2016

    The Immune Tolerance Network (ITN) accepts applications for novel clinical trials from all interested scientists from academia, industry and government, in the areas of: Allergy & Asthma, Autoimmune Diseases, Kidney & Liver Transplantation. Assays & Biomarkers: In addition, the ITN accepts applications for the development of novel tolerance assays or mechanistic studies for the purposes of establishing new surrogate markers of immune tolerance and investigating the mechanisms of clinical tolerance. For example, the ITN will consider proposals that seek to better understand clinical tolerance by utilizing ITN tolerance assay resources in existing or planned clinical trials that are funded through other sources.The ITN does NOT accept proposals for non-human or preclinical studies. NOTE: There is no specified application date for initial proposals which are referred to as Concept Proposals. You will be notified within 6-8 weeks of your application in regards to approval status. 

    Program: Immune Tolerance Network

    Award Amount: Unknown

  • The Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership: Type 2 Diabetes Project (AMP T2D) Request for Proposals 5
    Start: September 7, 2016      End: December 31, 2016

    RFP Title: Call for Genotypic and Phenotypic Data related to Nonalcoholic Steatohepatitis (NASH) for Incorporation into the Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal. The open access AMP T2D Knowledge Portalhas been built to generate new biologic and disease state understanding by maximizing the ability to explore rare and common genetic variants across quantitative and qualitative phenotypes related to the many indications related to T2D and its complications. One such complication that has become of increasing interest is Nonalcoholic Steatohepatitis (NASH). As such, FNIH is seeking proposals from organizations to contribute high-quality human genome sequence, clinical, and molecular phenotypic data for NASH to the AMP T2D Knowledge Portal. Proposals to contribute existing data sets as well as proposals to derive new genotyping data from readily available and appropriately consented samples will be considered. The consortium is expanding the KP to federated sites outside the U.S. in order to facilitate inclusion of global data in order to accommodate regional requirements. By participating in this global collaborative effort, awardees will help advance translational science and help identify new treatments for T2D and its complications. Data of interest include those derived from whole exome sequencing, whole genome sequencing, exome chip, or genome wide association analyses of large cohorts with corresponding and relevant individual level phenotypic data. Data from any and all geographic regions, races, and ethnicities are of great value to the knowledge portal and will contribute toward building the single most powerful resource for understanding the genetics of Type 2 Diabetes and its complications. In the interest of attaining critical scale, applications from consortia representing multiple cohorts are encouraged. Awardees will become active members of a growing AMP T2D collaborative group, which includes experts from multiple private, public, and non-profit institutions. Awardees will benefit from access to state of the art computational tools facilitated by harmonization and integration with extensive, well-phenotyped data from other sources. For more information, please contact Dr. Sanya Whitaker (swhitaker@fnih.org).

    Program: The FNIH AMP T2D consortium

    Award Amount: up to $500,000

    Duration: 1-2 Years

  • The Foundation For The National Institutes Of Health (FNIH) Accelerating Medicines Partnership: Type 2 Diabetes Project (AMP T2D) Request For Proposals 6
    Start: September 7, 2016      End: December 31, 2016

    RFP Title: Call for Genotypic and Phenotypic Data related to Diabetic Nephropathy for Incorporation into the Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal. The open access AMP T2D Knowledge Portal has been built to generate new biologic and disease state understanding by maximizing the ability to explore rare and common genetic variants across quantitative and qualitative phenotypes related to the many indications related to T2D and its complications. One such complication that has become of increasing interest is Diabetic Nephropathy (DN). As such, FNIH is seeking proposals from organizations to contribute high-quality human genome sequence, clinical, and molecular phenotypic data for DN to the AMP T2D Knowledge Portal. Proposals to contribute existing data sets as well as proposals to derive new genotyping data from readily available and appropriately consented samples will be considered. The consortium is expanding the KP to federated sites outside the U.S. in order to facilitate inclusion of global data in order to accommodate regional requirements. By participating in this global collaborative effort, awardees will help advance translational science and help identify new treatments for T2D and its complications. Data of interest include those derived from whole exome sequencing, whole genome sequencing, exome chip, or genome wide association analyses of large cohorts with corresponding and relevant individual level phenotypic data. Data from any and all geographic regions, races, and ethnicities are of great value to the knowledge portal and will contribute toward building the single most powerful resource for understanding the genetics of Type 2 Diabetes and its complications. In the interest of attaining critical scale, applications from consortia representing multiple cohorts are encouraged. Awardees will become active members of a growing AMP T2D collaborative group, which includes experts from multiple private, public, and non-profit institutions. Awardees will benefit from access to state of the art computational tools facilitated by harmonization and integration with extensive, well-phenotyped data from other sources.

    Program: The FNIH AMP T2D consortium

    Award Amount: up to $500,000

    Duration: 1-2 Years

  • The Foundation For The National Institutes Of Health (FNIH) Accelerating Medicines Partnership: Type 2 Diabetes Project (AMP T2D) Request For Proposals 7
    Start: 05:01pm September 7, 2016      End: 03:59pm December 31, 2016

    RFP Title: Call for Genotypic and Phenotypic Data related to Type 2 Diabetes and Complications for Incorporation into the Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal. The open access AMP T2D Knowledge Portal has been built to generate new biologic and disease state understanding by maximizing the ability to explore rare and common genetic variants across quantitative and qualitative phenotypes related to the many indications related to T2D and its complications. It is the vision of AMP that the AMP T2D Knowledge Portal will continually grow in content and in analytic capabilities. As such, FNIH is seeking proposals from organizations to contribute high-quality human genome sequence, clinical, and molecular phenotypic data for T2D, for T2D-related quantitative traits, and for T2D microvascular, cardiovascular, renal, and hepatic complications to the AMP T2D Knowledge Portal. Proposals to contribute existing data sets as well as proposals to derive new genotyping data from readily available and appropriately consented samples will be considered. The consortium is expanding the KP to federated sites outside the U.S. in order to facilitate inclusion of global data in order to accommodate regional requirements. By participating in this global collaborative effort, awardees will help advance translational science and help identify new treatments for T2D. Data of interest include those derived from whole exome sequencing, whole genome sequencing, exome chip, or genome wide association analyses of large cohorts with corresponding and relevant individual level phenotypic data. Data from any and all geographic regions, races, and ethnicities are of great value to the knowledge portal and will contribute toward building the single most powerful resource for understanding the genetics of Type 2 Diabetes. In the interest of attaining critical scale, applications from consortia representing multiple cohorts are encouraged. Awardees will become active members of a growing AMP T2D collaborative group, which includes experts from multiple private, public, and non-profit institutions. Awardees will benefit from access to state of the art computational tools facilitated by harmonization and integration with extensive, well-phenotyped data from other sources.

    Program: The FNIH AMP T2D consortium

    Award Amount: up to $500,000

    Duration: 1-2 Years

  • Diabetic Complications Consortium (DiaComp) Collaborative Funding Program: Diabetic Foot Ulcers - Planning Activities for Clinical Biomarker Studies
    Start: 12:01am November 3, 2016      End: 05:00pm March 10, 2017

    The purpose of this program is to support planning activities for the development of a multi-center study for clinical biomarkers and outcome measures for diabetic foot ulcers. It is also part of an effort by the NIDDK to support clinical studies that involve two or more institutions to build a collaborative framework for ongoing research on diabetic wound healing. Applications should propose a future clinical study based on the criteria listed below. The application should include a rationale for the future clinical study, documenting significance and need, and describe the potential impact of the clinical study on biomarkers and research infrastructure. Preliminary results and background to support the study and an overview of the study design should be provided. The latter should include an estimate of the number of subjects, entry criteria, and outcome measures. In addition, the application should describe the planning activities proposed to be conducted during the single year of this program. These may include meetings to develop the protocol, focus groups for the patient-centered outcomes, clinical studies to obtain preliminary data, quality control testing of patient sample analysis, biostatistical analysis to develop sample size calculations, or analysis of databases to inform recruitment strategies. The goal of the planning activities is to develop a complete study protocol for the validation of a biomarker or outcome measure for diabetic foot ulcers. Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Contact information: Richard McIndoe, PhD rmcindoe@augusta.edu

    Program: DiaComp

    Award Amount: up to $100,000

    Duration: 1 year

  • Michigan Regional Comprehensive Metabolomics Resource Core Pilot and Feasibility Projects
    Start: July 1, 2015      End: March 16, 2017

    The Project/Feasibility program is intended to provide opportunities for investigators to advance basic, clinical and translational biomedical science by incorporating metabolomic technologies into their research program. The goal of this program is to enable investigators to generate a sufficient body of preliminary information for a successful application for major research funding from NIH or other national granting agencies. Faculty or equivalent eligible to apply for NIH funding. We especially encourage applications from junior faculty (Assistant Professor or below) and those who have not previously utilized metabolomics in their research. Note: Investigators who have extensive use of metabolomic technology in their research are generally ineligible for funding. 

    Program: Michigan Regional Comprehensive Metabolomics Resource Core

    Award Amount: $50,000

    Duration: 1 year

  • The Chan Zuckerberg Initiative Pilot Projects for a Human Cell Atlas
    Start: March 15, 2017      End: April 15, 2017

    The goal of the International Human Cell Atlas project is to create a reference atlas of all cells in the healthy human body as a resource for studies of health and disease. As part of this effort, the Chan Zuckerberg Initiative seeks applications to support the Human Cell Atlas community’s convergence around standards, protocols, and best practices for the creation of a freely and openly available reference database of healthy human cells and tissues. We expect the reference Cell Atlas to ultimately include a variety of data types, including single-cell RNA sequencing, in situ hybridization imaging, proteomics, metabolomics, epigenetic information, low- and high-resolution images of biological samples, and more. For the initial phases of the project, we are especially interested in groups that can help evaluate protocols and best practices for the collection of single-cell molecular data, ideally by directly comparing multiple approaches to tissue preparation, data generation, or data analysis. Eligibility: All applicants must hold a PhD, MD, or equivalent degree and have a faculty position or equivalent independent investigator status at a college, university, medical school, or other research facility. Applications may be submitted by scientists at domestic and foreign non-profit and for-profit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local government, companies, and eligible agencies of the federal government. 

    Program: The Chan Zuckerberg Initiative

    Award Amount: An estimated budget is requested. The Chan Zuckerberg Initiative will work closely with successful applicants to arrive at a suitable budget after review.

    Duration: 1 year

  • Perelman School of Medicine, University of Pennsylvania, Center for Molecular Studies in Digestive and Liver Diseases Pilot and Feasibility Grant Program
    Start: January 1, 2016      End: May 15, 2017

    The purpose of the Center is to unite investigators with interests in digestive and liver physiology and disease and to stimulate others in the biomedical community to enter this area of research. One of the most important aspects of this effort is the funding of Pilot/Feasibility Projects. The Pilot/Feasibility Project should be related to the focus of the Center, which encompasses molecular studies on the biology or disease of the alimentary tract, pancreas, and liver. Relevant investigations include those in developmental biology, nutrition, regulation of gene expression, growth, differentiation and carcinogensis, the biology of stem cells, molecular genetics, gene therapy, and immunology, including growth factors and cytokines. Eligibility: All faculty members of the University scientific community who meet the eligibility requirements below are invited to submit proposals.

    Program: Perelman School of Medicine, University of Pennsylvania, Center for Molecular Studies in Digestive and Liver Diseases

    Award Amount: $20,000

    Duration: One Year

  • Nuclear Receptor Signaling Atlas (NURSA) Hub: Consensome Validation NURSA Data Source Projects (NDSPs)
    Start: 01:01am May 4, 2017      End: 05:00am June 19, 2017

    The mission of the Nuclear Receptor Signaling Atlas (NURSA) Hub is to improve the accessibility and re-usability of publicly-archived datasets of relevance to the nuclear receptor (NR) signaling research community.  To arrive at consensus physiological system- and organ-specific transcriptomic signatures of NR pathways, the NURSA Hub has added a new module to its Transcriptomine data analysis platform, called Consensome. In this feature, genes are ranked according to the frequency with which they are significantly differentially expressed in publicly archived datasets involving manipulation of a given NR pathway in a specific organ or physiological system. The rankings, or Consensomes, are available at https://www.nursa.org/nursa/transcriptomine/index.jsf. In addition to validating well-characterized NR target genes, many Consensomes contain highly ranked genes that represent potentially important, but currently underappreciated, transcriptional targets of NR signaling pathways. In this NDSP solicitation, we invite applications proposing bench validation of relationships between NR signaling pathways and gene(s) predicted by the Consensomes, but that are previously unpublished in the research literature. Letter of Intent due date: May 31, 2017.

    Program: NURSA

    Award Amount: $75,000

    Duration: 1 year

  • Melanoma Research Alliance (MRA) Request for Proposals: Team Science Awards
    Start: August 19, 2014      End: October 6, 2017

    Awards for team science are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Multidisciplinary teams of two or more established Principal Investigators and a Young Investigator with complementary expertise will receive up to $900,000 total over 3 years, to support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging and/or treatment of melanoma.Letters of Intent (LOIs) are due on October 6, 2017. Invited full length proposals from meritorious LOIs are due on January 9, 2018. Eligibility: Teams may consist of investigators from the same institution, different institutions, and may be international.

    Program: Melanoma Research Alliance

    Award Amount: Up to $900,000 total over 3 years

    Duration: 3 years

  • The Wisconsin Alzheimer’s Disease Research Center (ADRC) Request Research Proposals
    Start: October 26, 2015      End: October 13, 2017

    The Wisconsin Alzheimer’s Disease Research Center (ADRC) announces the availability of funds to support pilot/feasibility studies targeting research in Alzheimer’s disease (AD) and related disorders. The major objective of this program is to enhance novel AD-related research throughout the University of Wisconsin campus, and generate pilot data for larger peer-reviewed grants. Geriatric-focused applications are encouraged. 

    Program: Wisconsin Alzheimer’s Disease Research Center

    Award Amount: $30,000

    Duration: 1 Year

  • Pennington Biomedical Research Center Nutrition Obesity Research Center Pilot and Feasibility Grant 2017 Special RFA on "Nutrition, Obesity, and Cancer"
    Start: August 1, 2017      End: October 16, 2017

    Approximately $60,000 is available to fund one or two P&F grants around the theme of nutrition, obesity and cancer. The major objective of this program is to provide research support to develop preliminary data and/or potential novel approaches (methods) from pairs of investigators with one investigator from LSU-HSC in New Orleans (cancer expertise) and the other from Pennington Biomedical (obesity expertise). The hope for a Pilot and Feasibility Award is that it will generate enough preliminary data for the investigator(s) to obtain research funding by conventional mechanisms (e.g., R01). This program needs to have at least one of the 2 investigators (either from LSU-HSC or from PBRC) to be a young investigator while the other can be more a mentor in the execution of the scientific proposal. Letter of intent: September 5, 2017. 

    Program: Pennington Biomedical Research Center Nutrition Obesity Research Center

    Award Amount: $30,000 - $60,000

    Duration: 1 year

  • Joslin Diabetes Research Foundation Prevention Innovative Awards
    Start: August 24, 2017      End: October 31, 2017

    JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. JDRF Priority Areas for FY2018 Prevention Innovative Awards (1) Discovery and validation of biomarkers (including imaging approaches) to monitor risk, stage progression and evaluate responses to interventions of human type 1 diabetes in the at-risk setting (2) Use of clinical biosamples or data from natural history studies to better characterize disease pathogenesis, heterogeneity, stages, risk scores of progression, and slow and fast progression in the at-risk setting (3) Secondary prevention clinical trials using repurposed or novel agents as well as establishment of cohorts in which to conduct prevention trials (4) Development of insights around microbiota-induced immunoregulation or viral-induced autoimmunity relevant to prevention of human T1D

    Program: Joslin Diabetes Research Foundation

    Award Amount: up to $100,000

    Duration: 1 year

  • Joslin Diabetes Research Foundation Beta Cell Replacement Innovative Awards
    Start: August 24, 2017      End: October 31, 2017

    JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. JDRF Priority Areas in FY2018 (1) Development of novel and innovative encapsulation prototypes capable of supporting long-term allo- or xeno-geneic beta/islet cell survival with appropriate glucose regulation kinetics in an immune-competent host (2) Encapsulation device optimization and testing with hESC/iPSC-derived beta cell products that have demonstrated functional competence (3) Large animal and clinical testing of technologies that have robust pre-clinical proof-of-principle (4) Elucidation of mechanisms to improve durability and function of encapsulated beta cell sources, including but not restricted to: host recognition of materials leading to a foreign body/fibrotic response, oxygen limitation, glucose-stimulated insulin delivery kinetics, long-term cell density maintenance, optimal microenvironment at the implantation site to allow long-term cell viability and function, etc. (5) Modification of cells and/or associated materials to optimize local immune modulation for long-term beta cell/islet survival and function in open devices or bioengineered scaffolds without systemic immune suppression (6) Fostering standardization, head-to-head comparison of beta cell replacement systems, and sharing of data and reagents

    Program: Joslin Diabetes Research Foundation

    Award Amount: up to $100,000

    Duration: 1 year

  • Human Islet Research Network (HIRN) New Investigator Pilot Award
    Start: November 15, 2017      End: January 15, 2018

    The goal of this award is to support a small number of new investigators of exceptional creativity who propose to apply bold and highly innovative new research approaches to biological problems under current investigation in HIRN. The HIRN New Investigator Pilot Award is designed to provide support for early career investigators who may need funding to explore feasibility of a new concept in support of an eventual R01 application. Research supported by these awards would be expected to address significant barriers in Type 1 Diabetes research.The research proposed must be relevant to the goals of HIRN consortia. Letter of intent due date: December 15, 2017

    Program: The Human Islet Research Network (HIRN)

    Award Amount: $150,000 direct costs over the lifetime of the award

    Duration: Up to two years

  • "Exploration of the Diabetic Foot Ulcer Niche" - Collaborative Pilot Program
    End: January 25, 2018

    The purpose of this Pilot Program is to adapt and evaluate emerging techniques focused on defining cell types and subtypes and their three-dimensional context to the study of diabetic foot ulcers. This will be accomplished by funding pilot studies to conduct key establishing experiments that will be necessary to inform any future construction of an unbiased atlas of diabetic skin and foot ulcers. Pilot projects will be composed of multidisciplinary teams that consist of partnerships between: 1) clinical scientists with experience in diabetic foot ulcer biology and access to fresh human biopsies/surgical material for analysis, and 2) investigators with expertise in applying a diverse set of agnostic, medium- to high-throughput technologies with single cell-resolution to the systematic exploration of the cellular diversity of human tissues (e.g., CLARITY combined with highly multiplexed profiling of proteins and/or RNAs, imaging mass cytometry, etc.) or human tissue-derived cells (e.g., RNAseq, Dropseq, ATACseq, etc.). The objectives of the Pilot Program are to 1) establish protocols for the collection, preservation, storage, and processing of diabetic skin and foot ulcer tissue, 2) adapt and utilize agnostic, single cell-resolution technologies of tissues and tissue-derived cells to assess the cellular complexity of intact and wounded tissues in diabetic patients, and 3) critically evaluate limitations of current methodologies for their application to the context of diabetic foot ulcers and explore potential solutions to begin to bridge these gaps. Pilot projects should collect samples from routine clinical debridement that includes tissue at various locations in the wound and adjacent tissue. Samples for future analysis such as blood and microbiome/biofilms should also be collected and stored. It is expected that applicants will obtain appropriate consent to broadly share samples, de-identified patient information, and experimental data. Consent should also permit following the course of wound healing after sample collection in order to include that information in metadata associated with samples and their analysis.

    Program: DiaComp

    Award Amount: $750,000

    Duration: 1 year

  • UCSF Diabetes Research Center (DRC) Pilot and Feasibility Awards
    Start: January 29, 2018      End: February 26, 2018

    The DRC Pilot & Feasibility Program is funded through a Center grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to stimulate new directions in diabetes research regardless of a laboratory's traditional focus. Pilot funding of up to $50,000 per application is available for a duration of 12 months from the time of award. Enhanced Pilot & Feasibility Awards of up to $100,000 for each of one or two years will be considered for highly exceptional proposals in clinical and translational research studies, innovative partnerships between clinical and basic research or in development of broadly useful and innovative technologies. Projects initially selected for Enhanced Pilot & Feasibility awards only will be offered after approval by NIDDK officials. Enhanced Pilot & Feasibility award holders also will be eligible to apply competitively for further bridge funding.The reviewers will examine the proposals for innovative research that will generate, within one year, seed data sufficient for future NIH grant applications in any aspect of clinical or basic research directly related to type 1 or type 2 diabetes. One year projects that create new knowledge or capabilities that can be used widely throughout the local and extramural diabetes research community also may be submitted in response to this RFA. Collaborative efforts with UCSF faculty currently engaged in diabetes-related research may better enable the successful completion of the approved research programs. Eligibility: UCSF faculty

    Program: UCSF Diabetes Research Center

    Funding amount: $50,000

    Duration: 1 year

  • UCSD - UCLA Diabetes Research Center pilot and feasibility program
    Start: December 1, 2015      End: March 1, 2018

    The DRC P&F mechanism will fund innovative new projects that will explore the feasibility of novel testable concepts and enhance the endocrine/diabetes research scope within the institutions.  A special emphasis on promoting promising junior faculty involved with diabetes research is key to the UCSD/UCLA P&F mission. It is expected that P&F studies will generate preliminary data that will be used by these investigators in diabetes/endocrinology-related R01 applications in the years following their award.The DRC is also please to announce a new partnership with the CTSIs at UCLA, Cedars and UCSD to specifically support clinical and/or translational research relevant to diabetes.  The DRC strongly encourages submission of pilot and feasibility proposals in this area. Eligibility: All eligible investigators must have faculty appointments at UCLA, Salk, Cedars, or UCSD, and be independent investigators.

    Program: UCSD - UCLA Diabetes Research Center

    Award Amount: $40,000 - $50,00

    Duration: 1 Year

  • The NIH Eastern Regional Comprehensive Metabolomics Resource Core (ERCMRC) Pilot and Feasibility Project
    End: March 16, 2018

    The goal of the P&F Program is to increase the use of metabolomics in basic, clinical, and translational research, by collaborating with investigators who are new to the field of metabolomics, by developing teams and partnerships, and by conducting high-risks/high-impact research. The P&F program aims to form new multidisciplinary collaborations that will enhance the integration of new techniques to benefit multiple investigators. Applicants are encouraged to link basic, clinical, and translational research. Extending the collaborative nature of the research projects by matching funds from other mechanisms is encouraged. Eligibility: All basic, translational, or clinical investigators located at institutions within the United States who are eligible to apply as a PI for NIH grants (https://grants.nih.gov/grants/who-is-eligible.htm). Young investigators and investigators who are new to the field of metabolomics are especially encouraged to apply.

    Program: The NIH Eastern Regional Comprehensive Metabolomics Resource Core (ERCMRC)

    Award Amount: up to $50,000

    Duration: 1 year

  • Resource Center for Stable Isotope-Resolved Metabolomics (RC-SIRM) Pilot and Feasibility Grant Program
    End: March 16, 2018

    The RC-SIRM at University of Kentucky provides extensive collaborative services and unique capabilities for metabolomics, with a strong emphasis on stable isotope resolved metabolomics (SIRM).The goal of the Pilot and Feasibility Program is to promote the use of metabolomics in translational research projects by providing analytical support for investigators – both new to and experienced in the metabolomics field – in the area of SIRM studies. SIRM requires experimental design, sample preparation, analyses, data processing, and biochemical interpretation that have unique challenges. Potential applicants are strongly encouraged to discuss potential projects with the RC-SIRM staff, in order to generate an appropriate study design that uses SIRM to address metabolic questions of pathways, networks, flux, apportionment of specific carbon, nitrogen, and other atoms (such as one-carbon metabolism, source of hydride in NADPH, etc.), and other areas that require SIRM technologies. Matching funds from other sources are encouraged. Data reduction and interpretation is usually extensive, and requires specialized knowledge and software tools. Various levels of assistance can be provided as appropriate. Eligibility: any researcher who is eligible to apply as a Principal Investigator (PI) for NIH funding may apply.

    Program: Resource Center for Stable Isotope-Resolved Metabolomics (RC-SIRM)

    Award Amount: up to $50,000

    Duration: 1 year

  • Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Pilot and Feasibility Program
    End: March 16, 2018

    The Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Pilot and Feasibility Program is focused on the discovery, validation, or qualification of CKD biomarkers in adults and children. The program accepts applications from two focused areas: 1. Applications proposing studies of biomarkers that are measured in human blood, urine, or renal tissue, or extracted from radiographic/imaging data and that seek to address important research questions related to the occurrence, progression, and/or consequences of CKD. 2. Applications proposing the development and/or evaluation of new statistical methods relevant to biomarkers which are specifically related to CKD biomarkers.

    Program: Chronic Kidney Disease Biomarkers Consortium (CKD BioCon)

    Award: $75,000

    Duration: 1 year

  • Southeast Center for Integrated Metabolomics Pilot and Feasibility Projects
    Start: January 1, 2016      End: March 16, 2018

    ECIM is now seeking proposals for 12-month pilot projects in metabolomics. The goal of this initiative is to enhance metabolomics research by providing support for investigators new to the field, the development of new teams and partnerships, and high-risk/high-impact research. Awards are intended to support projects that will provide preliminary data for new extramural grant application submissions. The review process will emphasize innovation and the potential of the work to have a significant impact on an important research problem. While proposals of up to $50,000 in total costs will be accepted, SECIM is dedicated to funding as many unique and innovative projects as possible with goals of expanding the center's capabilities and enhancing metabolomics research capacity across the nation. Thus, applications requesting $20,000 or less will receive preference over those with higher budgets. Requests for salary for the Principal Investigator or personnel, laboratory costs or extramural services outside of SECIM are not permissible. All funds will be awarded in credit toward SECIM services, or in payment for the project's materials and supplies.

    Program: Southeast Center for Integrated Metabolomics

    Award Amount: $50,000

    Duration: 1 year

  • Mayo Clinic Metabolomics Resource pilot projects and feasibility projects
    Start: January 1, 2016      End: March 16, 2018

    The goal of the Pilot and Feasibility Program is to enhance metabolomics research crucial to translational projects by providing investigators who are new to the metabolomics field the opportunity to explore the use of metabolomics in their research and support high-risk and high-impact research.The Mayo Clinic Metabolomics Resource Core Pilot and Feasibility Program aims to form new multidisciplinary collaborations that will enhance the integration of the techniques offered at Mayo Clinic and benefit multiple investigators.Potential applicants are encouraged to link basic, translational and clinical research. Extending the collaborative nature of research projects with funds from other mechanisms is encouraged.   

    Program: Mayo Clinic Metabolomics Resource

    Award Amount: $50,000

    Duration: 1 year

  • West Coast Metabolomics Center - Pilot and Feasibility Projects
    End: March 23, 2018

    The WCMC provides extensive services for metabolomics research. The goal of the Pilot and Feasibility Program is to enhance metabolomics research crucial to translational projects by providing support for investigators new to the metabolomics field, the development of new teams and partnerships, projects that link genomics, proteomics and metabolomics, and high risk/high impact research. The Pilot and Feasibility Program aims to form new multidisciplinary collaborations that will enhance the integration of new techniques that benefit multiple investigators. Potential applicants are encouraged to link basic, translational, and clinical researchers. Extending the collaborative nature of research projects by matching funds from other mechanisms is encouraged.

    Program: West Coast Metabolomics Center

    Award Amount: $50,000

    Duration: 1 year

  • New York Regional Center for Diabetes Translation Research Pilot and Feasibility program
    End: April 15, 2018

    The New York Regional Center for Diabetes Translation Research (CDTR) announces the availability of Pilot and Feasibility (P&F) awards for new projects that address a diabetes-related translational research question. Translational projects related to diabetes prevention or control are eligible if they are use methodologies such as: community-based participatory research, implementation or dissemination science, natural experiment methods, as well as quantitative or qualitative methods to assess novel interventions and/or technologies to improve diabetes prevention or diabetes care and outcomes at the individual, group or population level. The CDTR website http://www.newyorkregionalcdtr.org provides information about resources and consultation services to support diabetes-related translational research. The P&F funds are intended to enable CDTR member investigators to generate preliminary data for seeking extramural funding of their project. P&F funds are not intended to support or supplement ongoing diabetes research programs. Recipients must hold the rank of Assistant Professor or higher at the time of the award. Letter of Intent due on March 15, 2018.

    Program: New York Regional Center for Diabetes Translation Research

    Award Amount: $5,000

    Duration: 1 Year

  • Michigan Metabolomic and Obesity Center(MMOC) and Michigan Nutrition and Obesity Research Center (MNORC) Pilot and Feasibility Program
    End: May 3, 2018

    The purpose of the MNORC Pilot /Feasibility (P/F) Grant Program is to promote research on the biological and behavioral determinants of obesity, and to develop interventions to reduce obesity and its disease sequelae using basic, clinical, or population approaches. The P/F program’s aim is to enable both new and established University of Michigan investigators to generate sufficient preliminary information for a successful application for major research funding from NIH or other national granting agencies. Grant proposals may be in areas of basic biomedical research or in clinical, epidemiological, or translational research, e.g. interventions in clinical or population-based setting. Animal or human models may be considered. Grant proposals involving cross-disciplinary expertise, Faculty from different UM schools, and that utilize the core laboratories of the MNORC are especially encouraged. The MNORC 2017 Call for Proposals aims to foster research addressing key questions in the areas of: Pathogenesis, diagnosis, prevention, or control of obesity; complications of obesity or related endocrine or metabolic disorders (e.g. counter-regulatory proteins, metabolic syndrome); neuro-peptides that may control eating behavior or energy expenditure; adipose tissue biology; influence of gut flora on nutrient absorption and cellular functions related to energy utilization. Translational research projects are encouraged and should focus on research advances into clinical practice or population-based interventions related to obesity, and include identification of barriers to widespread adoption of new science and the testing of interventions to overcome these barriers. Eligibility:  Individuals who have full-time instructional or research faculty positions at the University of Michigan are eligible to apply as Principal Investigators of P/F proposals.

    Program: MMOC/MNORC

    Award Amount: up to $50,000

    Duration: 1 year

  • ReBuilding a Kidney (RBK) Partnership Project Program
    Start: May 20, 2016      End: May 4, 2018

    (Re)Building a Kidney is an NIDDK-funded consortium of research projects working to optimize approaches for the isolation, expansion, and differentiation of appropriate kidney cell types and their integration into complex structures that replicate human kidney function.Partnership Projects are requested to add value and complement ongoing studies in the RBK Consortium and must not duplicate ongoing studies. Each Partnership Project will receive funding for 1 year but may be renewed for a second year depending on progress and programmatic priority and need. 2018 subject areas of interest are LIMITED to Physiologic Function and Repair/Regeneration.

    Program: (Re)Building a kidney

    Award Amount: up to $150,000

    Duration: 1-2 years

  • The New York Obesity Nutrition Research Center Pilot Feasibility Grant Program
    End: May 11, 2018

    Three types of applications will be considered:1. Proposals from Assistant Professors or Postdoctoral Fellows currently transitioning to FACULTY STATUS to carry out preliminary studies to be used for an NIH grant application.  Applicants with prior funding through this or similar programs, graduate students, or Postdoctoral Fellows (other than as above) are NOT eligible to apply; 2. Proposals for innovative/high-risk projects by established investigators in the field of obesity/ingestive behavior.  Support for current research is NOT eligible; 3. Proposals from established investigators, without prior funding in obesity, who wish to undertake an obesity-related project. Faculty members and postdoctoral fellow are encouraged to apply.

    Program: The New York Obesity Nutrition Research Center

    Award Amount: up to $50,000

    Duration: 1 year

  • University of Pittsburgh O'Brien Urology Research Center Pilot and Feasibility Program
    End: May 31, 2018

    The O’Brien Urology Research Centers request applications for pilot projects in urology research. Ideal projects will facilitate accumulation of preliminary data that can be used for future grant applications, and expand the scope of urology research under the auspices of the currently funded O’Brien Centers (see list below). Projects that support new investigators with a faculty appointment not already R01 or equivalently funded are especially encouraged. Established investigators not currently doing benign urology research in alignment with the funded centers are also encouraged to apply.

    Program: University of Pittsburgh O'Brien Urology Research Center

    Award Amount: up to $150,000

    Duration: 1-2 Years

  • Nutrition Obesity Research Center at University of California San Francisco Pilot and Feasibility Program
    End: June 4, 2018

    The Nutrition Obesity Research Center (NORC) announces the 2017 RFA for Pilot and Feasibility Grants to provide pilot funding to pursue novel ideas broadly relevant to nutrition, obesity, and metabolism research. The NORC P&F Program is funded by NIDDK to support junior faculty and established investigators wishing to pursue new directions in NORC related research.

    Program: Nutrition Obesity Research Center at University of California San Francisco

    Award Amount: up to $50,000

    Duration: 1 year

  • Washington University in St. Louis, Nutrition Obesity Research Center
    Start: January 1, 2014      End: June 18, 2018

    The major objective of this program is to provide research support to test innovative hypotheses involving nutrition/metabolism-related research. This research should involve some aspect of nutrient absorption, metabolism, or cell signaling or genetic aspects that are nutrition-related.  It is hoped that a Pilot and Feasibility Award will generate enough preliminary data for the investigator to obtain research funding by conventional mechanisms (e.g., R01).  We also hope this program will encourage young investigators and more established investigators in other fields to approach problems which are relevant to our understanding of nutrient metabolism and function and increase our understanding of the basic and clinical aspects of nutrition in the prevention, etiology, pathophysiology, and therapy of disease.

    Program: Washington University in St. Louis, Nutrition Obesity Research Center

    Amount: Up to $30,000

    Duration: 1 Year

  • Washington University in St. Louis Diabetes Research Center Pilot and Feasibility Grant Program
    End: July 16, 2018

    The Washington University Diabetes Research Center anticipates awarding new Pilot & Feasibility Grants starting 12/01/18. Funding should support the generation of preliminary data leading to the submission of new applications for independent (NIH, JDRF, or ADA) research grants. Faculty members from any department at Washington University are encouraged to apply. Applicants must hold a faculty appointment and be independent investigators. Postdoctoral Fellows or their equivalent are not eligible.

    Program: Diabetes Research Center, Washington University in St. Louis

    Award Amount: up to $50,000/year

    Duration: 1-2 Years

  • Boston Nutrition Obesity Research Center Pilot and Feasibility Program
    End: July 23, 2018

    The mission of the NIDDK-funded Boston Nutrition Obesity Research Center (BNORC) is to facilitate and support the conduct of cutting edge basic and translational research in the fields of nutrition and obesity science in the Boston area. BNORC’s Pilot and Feasibility Program provides funding on a competitive basis for new investigators who are transitioning to an independent line of research or established investigators with novel ideas in the area of nutrition and obesity research. Applications that address the themes of the Center will be given higher priority. These themes are: Nutrient Metabolism in Health and Disease, Brain Control of Feeding Behavior and Metabolism, Environmental and Genetic Influences on Obesity and Related Chronic Diseases. Letter of intent due date: July 23, 2018 

    Program: Boston Nutrition Obesity Research Center

    Award Amount: up to $25,000

    Duration: 1-2 Years

  • Michigan Diabetes Research Center and Michigan Center for Diabetes Translational Research Pilot/Feasibility Grant Program
    Start: June 5, 2015      End: August 6, 2018

    The purpose of this Pilot /Feasibility Study (P/FS) Grant Program is to promote research in diabetes by new and established investigators at the University of Michigan. The ultimate goal of the program is to accelerate the pace of research and enable awardees to generate sufficient preliminary data for successful applications for major research funding from the NIH or other national granting agency.Grant proposals may be in areas of basic biomedical, clinical, behavioral, epidemiological, health services, or type 2 translational research and should address key questions regarding the pathogenesis, diagnosis, prevention, or treatment of diabetes, its complications, or related endocrine or metabolic disorders (for example: obesity, metabolic syndrome, counter-regulatory proteins). Type 2 translational research projects should focus on the translation of research advances into clinical or community practice and include the identification of barriers to widespread adoption of new science and the testing of interventions to overcome these barriers. Eligibility: Individuals who have full-time instructional, research or clinical faculty positions at the University of Michigan

    Program: Michigan Diabetes Research Center; Michigan Center for Diabetes Translational Research

    Award Amount: $50,000

    Duration: One Year

  • The University of Arizona Southwest Environmental Health Sciences Center Pilot Projects
    Start: August 10, 2015      End: August 10, 2018

    CURATOR'S NOTE: This application has a rolling deadline. The start date and end date below are meant to suggest that applications can be submitted at any time. Visit the website for further information. The Southwest Environmental Health Sciences Center (SWEHSC), an NIEHS funded Center at the University of Arizona, announces the availability of funds for pilot projects.  To assist center members as they prepare to submit grant applications specifically to NIEHS, we are moving to a more flexible and targeted approach to using the funds that are budgeted for pilot projects.  Rather than complete projects from start to end with full budgets, a set submission date, and open competition for a limited number of grants, the center will now be evaluation requests for specific assistance on a rolling basis.  There are no limits to the assistance that can be requested, either in terms of the type of assistance, time-frame for the assistance, or the dollar value.  It is anticipated that awards as little as $500 will be given regularly throughout the year. Eligibility:  The Pilot Projects program announcements have resulted in applications from across the state.  Since the funding increase in 2007, 68 applications have been received from 19 different University Departments or Centers at the University of Arizona, Northern Arizona University, and Arizona State University.

    Program: The University of Arizona Southwest Environmental Health Sciences Center

    Award Amount: $500 - $80,000

    Duration: No time frame specified.

  • University Of Wisconsin-Madison—Washington University Diabetes Research Center Collaborative Pilot & Feasibility Awards
    End: August 20, 2018

    Funds from the Washington University Diabetes Research Center are dedicated to supporting Pilot & Feasibility Awards through a collaborative program with University of Wisconsin-Madison. The goal of these funds is to develop preliminary data leading to the submission of new applications for independent (NIH, JDRF, or ADA) research grants. Faculty members from any department at University of Wisconsin-Madison are encouraged to apply.

    Program: University Of Wisconsin-Madison—Washington University Diabetes Research Center

    Award Amount: contact program

    Duration: 1 year

  • University of Kentucky—Washington University Diabetes Research Center Collaborative Pilot & Feasibility Awards
    End: August 29, 2018

    Funds from the Washington University Diabetes Research Center are dedicated to supporting Pilot & Feasibility Awards through a collaborative program with University of Kentucky. The goal of these funds is to develop preliminary data leading to the submission of new applications for independent (NIH, JDRF, or ADA) research grants. Applicants must hold a faculty appointment and be independent investigators in any department at University of Kentucky. Postdoctoral Fellows or their equivalent are not eligible. 

    Program: University of Kentucky—Washington University Diabetes Research Center

    Award Amount: up to $40,000

    Duration: One Year

  • University of Utah—Washington University Diabetes Research Center Collaborative Pilot & Feasibility Awards
    End: August 29, 2018

    Funds from the Washington University Diabetes Research Center are dedicated to supporting Pilot & Feasibility Awards through a collaborative program with the University of Utah. The goal of these funds is to develop preliminary data leading to the submission of new applications for independent (NIH, JDRF, or ADA) research grants. Applicants must hold a faculty appointment and be independent investigators in any department at the University of Utah. Postdoctoral Fellows or their equivalent are not eligible. 

    Program: University of Utah—Washington University Diabetes Research Center

    Award Amount: up to $40,000

    Duration: One Year

  • University of Chicago Digestive Diseases Research Core Center Pilot and Feasibility Program
    End: August 31, 2018

    The overarching theme of the DDRCC is research in Digestive Health and Disease, including inflammatory bowel diseases (IBD) and related areas of intestinal inflammation, immunology, the gut microbiome, metabolism, and epithelial biology/cancer of the GI tract.  Pilot and Feasibility applications focused on these “mission” areas will receive higher priority. Broad aspects of basic and translational/clinical research related to enteric microbiology, inflammation, and immunology of the digestive tract and pathogenesis, genetics, pathophysiology, and bench-to-bedside aspects of inflammatory bowel diseases will be given higher priority.  In addition, proposals focused on the examination of growth and differentiation, cancer biology, intestinal epithelial biology and pathobiology of the gastrointestinal tract (including the luminal GI tract, liver, pancreas, biliary system, etc.), as well as basic or clinical research in the areas of nutrition, metabolism, and digestive diseases are appropriate topics for Pilot & Feasibility studies. 

    Program: University of Chicago Digestive Diseases Research Core Center

    Award Amount: $25000-$37000

    Duration: one year

  • MMPC Mouse Microbiome Metabolic Research Program (MMMRP)
    End: September 3, 2018

    The mission of MMPC’s Mouse Metabolic Research Program is to support the development and application of mouse phenotyping technologies to advance microbiome-related research. A clear rationale for how/why the microbiome, such as gut microbiome, lung microbiome, etc, might be expected to impact metabolic phenotyping endpoints in mice must be provided in each proposal. Although there is no requirement for direct collaboration with an MMPC, expected project outcomes should have the potential to add value to the MMPC program. The Mouse Microbiome Metabolic Research Program (MMMRP) is a competitive grants up to $125,000 (total costs) for one year. The program supports for pilot and feasibility projects that incorporate microbiome research into mouse metabolic phenotyping studies. All studies should demonstrate clear potential to advance the mission of the MMPC (www.mmpc.org). Any independent investigator or post-doctoral fellow at a US institution is eligible to apply. 

    Program: Mouse Metabolic Phenotyping Center

    Amount: up to $125,000

    Duration: one year

  • Stanford University Diabetes Research Center Pilot and Feasibility Program
    End: September 4, 2018

    The Diabetes Research Center (Stanford DRC) is soliciting new Pilot and Feasibility Projects.  The focus of the Stanford DRC Pilot and Feasibility Program is to provide seed funds to help develop new investigators as well as support innovative and/or high-risk proposals from more senior investigators involved in any aspect of diabetes related research, including but not limited to basic sciences, economics, population sciences, translational research and clinical research. Letter of intent due date: August 1, 2018.

    Program: Stanford University Diabetes Research Center

    Award Amount: up to $50,000

    Duration: One Year

  • Texas Medical Center Digestive Disease Center Pilot project
    Start: September 25, 2015      End: September 28, 2018

    The 2015-2016 Pilot Feasibility Program will begin in October.  The first announcement will go out in late September or early October.  Letter of Intents are typically due in November. Official applications shortly after.  They are reviewed by our panel and committee members and awardees are announced in January.  (Start and End Dates for application are approximated, check website frequently for accurate dates).The Texas Medical Center Digestive Diseases Center (DDC) announces the availability of grant funds to support pilot/feasibility (P/F) projects in the area of GI-related research. These funds will support projects related to the theme for the DDC - GI infection and injury. GI is defined as the gastrointestinal tract, liver and pancreas. Injury is defined as drug, genetic, ischemic, inflammatory, surgical, nutritional, or stress-induced injury to the gastrointestinal tract. Injury also includes gastrointestinal adaptation and stem cells. Projects should relate to this theme. Awards will be for ~ $15,000 to $35,000 for a period of one year (earliest start date is March 1, 2017). A committee composed of the DDC Internal Advisory Board, plus ad hoc members, will evaluate proposals. The purpose of these grants is to help young investigators establish an independent research program and to encourage the involvement of established investigators not currently working in the GI area. It is highly recommended that members of the DDC Advisory Committee (listed above) be consulted during the preparation of applications. All faculty members from the Texas Medical Center are eligible. Faculty members at otherinstitutions are eligible if they submit a grant that collaborates with a faculty member at the Texas Medical Center who is also a member of the Digestive Diseases Center. Trainees who are recipients of an NRSA individual award (F32) or are supported by an institutional training grant (T32) are eligible for P/F funds, if they are in their last year of training, have had at least one year of research laboratory experience, and have suitable expertise and independence to design and carry out the planned experiments. Trainees should have a commitment from a senior scientist to sponsor their projects. US citizenship or permanent resident status is not required. Funding preference will be given to junior faculty. Notice of Intent Due Monday, August 31, 2018.

    Program: Texas Medical Center Digestive Disease Center

    Award Amount: $15,000-35,000

    Duration: 1 year

  • UCLA Children's Discovery and Innovation Institute Seed Grant
    Start: September 10, 2015      End: October 1, 2018

    The UCLA Children's Discovery and Innovation Institute (CDI) Seed Grants provides awards of up to $30,000 for one year for junior faculty conducting child health research to generate preliminary data needed for subsequent applications to federal and private funding agencies. Eligible faculty for Principal Investigator must hold a primary or secondary appointment in the Department of Pediatrics at the level of Clinical Instructor, Assistant Professor, or Associate Professor. At least one Co-Investigator must be a faculty member whose primary appointment is outside the Department of Pediatrics. Substantive collaboration with multiple UCLA schools and departments is emphasized for this award. The CDI, established in 2013 at the David Geffen School of Medicine at UCLA, encourages innovative and multidisciplinary child health research and research training at UCLA across the spectrum of basic, translational, clinical, and health services research. Eligible faculty for Principal Investigator must hold a primary or secondary appointment in the Department of Pediatrics at the level of Clinical Instructor, Assistant Professor, or Associate Professor. 

    Program: UCLA Children's Discovery and Innovation Institute

    Award Amount: $30,000

    Duration: One Year

  • Center for Interdisciplinary Research on AIDS (CIRA) at Yale University Pilot Project
    Start: July 23, 2015      End: October 8, 2018

    The Center for Interdisciplinary Research on AIDS (CIRA) at Yale University seeks letters of intent for its annual Pilot Projects in HIV/AIDS Prevention Research program. The goal of the program is to provide pilot funding that will result in additional externally funded research projects.  We will consider letters of intent for applications for short-term funding support for preliminary, formative, or feasibility studies that will inform the development of larger, peer-reviewed research that can compete successfully for NIH or other funding. Applicants may propose to collect new data or to analyze data from completed R01, R03, R21 grants, other externally-funded projects, or previous CIRA pilot projects for the purpose of developing a new research agenda and funding. Eligibility: The program is open to full-time faculty and postdoctoral fellows and associates at Yale University, The Institute for Community Research (ICR), and the Center for Health, Intervention, and Prevention (CHIP) at UConn.  Investigators from other universities or colleges and community-based organizations are eligible to apply in collaboration with a Principal Investigator based at Yale, ICR, or CHIP. It is our expectation that awardees will hold an appointment at one of these institutions for at least one year past the award date. Letter of intent: August 20, 2018

    Program: Center for Interdisciplinary Research on AIDS (CIRA) at Yale University

    Award Amount: $30,000

    Duration: One Year

  • Cystic Fibrosis Foundation Clinical Pilot and Feasibility Award
    End: 11:59pm October 15, 2018

    The intent of the Clinical Pilot and Feasibility Award is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger scale research and/or multi-center, collaborative clinical trial. Special consideration will be given to those projects that pursue new approaches, under-researched topics, or more creative avenues of research to address the problems of cystic fibrosis. Applications for continued funding of the same project, or for long-term support of an investigator, will not be considered. The top 10 areas prioritized by the CF community are listed below: (1)Respiratory microorganism detection and treatment (2)Gastrointestinal symptoms (including, but not limited to, GERD, DIOS, and pancreatitis) (3) Reducing treatment burden (4)CF-related diabetes (5)Diet and nutrition (6) Mental health (7) CF-related liver disease (8)Exercise (9) Sinus disease (10)Allergies and asthma

    Program: Cystic Fibrosis Foundation

    Award Amount: $50,000

    Duration: 1-2 years

  • Joslin Diabetes Research Foundation Beta Cell Replacement Innovation Awards
    End: October 31, 2018

    JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. Proposals should address key outstanding questions and have the potential to lead to a change in the current paradigm or conventional wisdom and/or lead to a groundbreaking discovery. Preliminary data is not required in the proposal but the underlying premise, goal, or hypothesis must be plausible and testable and the proposal must be focused with a well- defined goal that is achievable within the timeframe of the award. The JDRF Beta Cell Replacement program strategy is designed to achieve the ultimate goal of creating a product with a safe renewable beta cell source capable of restoring glucose control and delivering long-term insulin independence without the need for chronic immunosuppression therapy. Priority areas include (1) Cell source: Identify the best cell source and composition;Reprogram somatic cells in vitro to functional insulin-producing cells;Leverage early clinical trial data to improve next-generation products (2)Cell survival and immune protection:Bioengineered delivery devices (encapsulation, scaffolds, hydrogels); Strategies to mitigate fibrosis and increase oxygenation; Beta cell survival agents to help preserve graft function; Device-less approaches include cell modification by genome editing and combination of immune and beta cell replacement therapies (3) Accelerate clinical translation: Standardize reagents: define preclinical animal models most predictive of human responses;Establish implantation site: engineer extrahepatic implantation sites to promote engraftment via scaffolds.

    Program: Joslin Diabetes Research Foundation

    Award Amount: $100,000

    Duration: one year

  • Joslin Diabetes Research Foundation Beta Cell Regeneration and Survival Innovation Awards
    End: 11:59pm October 31, 2018

    JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. Proposals should address key outstanding questions and have the potential to lead to a change in the current paradigm or conventional wisdom and/or lead to a groundbreaking discovery. Preliminary data is not required in the proposal but the underlying premise, goal, or hypothesis must be plausible and testable and the proposal must be focused with a well- defined goal that is achievable within the timeframe of the award.? Specific information regarding JDRF’s Beta Cell Regeneration and Survival research priority areas include (1) Beta cell survival therapy (2) Beta cell regeneration therapy (3) Biomarkers and clinical path initiatives.? The proposal must not be related to existing JDRF-funded research unless it involves a novel concept or hypothesis.? The concept does not require preliminary evidence in T1D but must be applicable to T1D in the future.? The Innovative Grant Mechanism is not intended to support proposals aiming to incrementally advance existing hypotheses or ongoing areas of research, or proposals with the sole goal of generating novel reagents or resources.? Applications proposing novel strategies for targeted delivery of beta cell therapeutics are of particular interest.

    Program: Joslin Diabetes Research Foundation

    Award Amount: $100,000

    Duration: one year

  • Boston Area Diabetes Endocrinology Research Center Pilot Grants
    End: November 1, 2018

     The Boston Area Diabetes Endocrinology Research Center is funded by the National Institute of Diabetes and Digestive Diseases (NIDDK) to support research in Diabetes and its complications. Letter of Intent: September 28, 2018

    Program: Boston Area Diabetes Endocrinology Research Center

    Award Amount: Up to $30,000

    Duration: unknown

  • Melanoma Research Alliance (MRA) Request for Proposals: Awards for Young Investigators
    Start: August 19, 2015      End: November 2, 2018

    Young Investigator Awards aim to attract early career scientists with novel ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma researcher leaders. Awardees will be provided up to $75,000 per year for 3 years to accomplish innovative, translational research projects. Eligibility: Applicants must be within 4 years of their first independent, full time academic faculty appointment at the time of application at the level of Assistant Professor (or equivalent position). All applicants must complete and return the Applicant Eligibility Checklist by October 19, 2018.

    Program: Melanoma Research Alliance

    Award Amount: Up to $75,000 per year

    Duration: 3 years

  • University of Alabama at Birmingham Diabetes Research Center
    Start: September 1, 2015      End: November 5, 2018

    Research Focus:  The pilot and feasibility program is intended to provide seed support for new and innovative research projects directed at basic, biochemical, translational, clinical, and community-based research questions that broadly pertain to diabetes, diabetes complications, and cardiometabolic disease. Pilot projects should be designed to generate sufficient data as the basis for further extramural funding (e.g., R01 applications) in order to substantially pursue and expand the line of investigation.  In fact, in order to respond to NIH criteria for competitive renewal of the DRC, a key priority for your application should be to focus on subsequent extramural or R01 grant funding.  Thus, your application will be reviewed with this in mind so please provide a short paragraph indicating how the award will facilitate R01 application development and the submission of a proposal.  We will entertain 2 year projects if justification for the need is made in order to effectively develop an R01 (you will have to reapply in November of 2016 to get funded for your second year).Eligibility:  Funding will be available to full time UAB faculty members who must meet one of the criteria listed below.  Please note that applications from post-doctoral fellows will be considered if there is a clear plan and written documentation for transition to a faculty position at UAB before the initiation date of the pilot grant award.  Post-doctoral applicants will be asked to identify a faculty member who will provide research advice, but the work should support independent research and career development for the fellow/junior faculty member.1. Junior investigators (e.g., Associate Professors or below who have not been PI on a previous NIH R01 grant).2. Established investigators with no previous work in diabetes who wish to apply their expertise to a problem in this area.3. Established investigators in diabetes who want to pursue high impact/high risk projects to test truly innovative ideas that represent a clear departure from ongoing research interests.4. Note:  We will also consider multidisciplinary projects that involve both basic and clinical scientists who combine efforts in ‘translational’ research protocols, which could not be conducted by basic or clinical scientist(s) alone. Eligibility: UAB Faculty members who meet one of the criteria listed, post-doctoral fellows will be considered if there is a clear plan and written documentation for transition to a faculty position at UAB before the initiation date of the pilot grant award. 

    Program: Diabetes Research Center, University of Alabama at Birmingham

    Award Amount: $20,000 - $50,000

    Duration: 1 Year

  • UNC Nutrition Obesity Research Center
    Start: April 1, 2014      End: November 12, 2018

    The primary objective of the Pilot & Feasibility Grant Program is to support the development of innovative research in nutrition and obesity. The program is specifically designed to help investigators collect preliminary data sufficient enough to support a grant application for independent research support and published work. Project Criteria: Pilot & Feasibility projects may be biomedical, epidemiological, clinical or translational. They may include laboratory or non-laboratory research projects that focus either on human nutrition or on animal work that could be translated to human nutrition. Human nutrition projects may focus on inpatient or outpatient studies or on epidemiological/community-based research that is social or behavioral in nature. Applicant Eligibility: The applicants must be a faculty member at UNC-CH who is a (1) new investigator without current or past NIH research support (R01, P01, or R24) as a PD/PI, or (2) an established, funded investigator with no previous work experience in nutritional sciences, and/or obesity who wishes to test the applicability of their expertise to a nutritional science and/or obesity-related problem. Funding: The NORC funds 1-year grants up to $20,000. The actual amount of the award and number of awards made will depend upon the quality of the proposals received and the availability of funding. Expenditures may begin at any time after the project’s start date (April 1st); however, the entire award should be expended within one year of receipt. Renewal for a second year of funding is possible for meritorious projects that have made appropriate progress during the first year. P&F funding is not intended for the extension of projects for which it would be appropriate to submit a research project grant application. Funds are also not intended to support or supplement ongoing research projects.

    Program: UNC Nutrition Obesity Research Center

    Amount: $20,000

    Duration: 1 year

  • Yale School of Medicine Diabetes Research Center Feasibility Program
    Start: November 9, 2015      End: November 19, 2018

    The DRC Pilot and Feasibility Study Award is intended to provide modest support that will allow an investigator the opportunity to develop sufficient preliminary data to provide the basis for an application for independent research support. Pilot and Feasibility Study support is not intended for large projects by established investigators which would otherwise be submitted as a separate research grant application. Pilot and feasibility funds are also not intended to support or supplement current ongoing funded research by an investigator. Eligibility: Yale Faculty at the time of appointment

    Program: Yale School of Medicine Diabetes Research Center

    Award Amount: $35,000

    Duration: One Year

  • The University of Pennsylvania Diabetes Research Center Pilot and Feasibility Grant Program
    Start: September 1, 2015      End: December 3, 2018

    The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators. Eligibility: Applications are invited from the Penn DRC community each fall

    Program: The University of Pennsylvania Diabetes Research Center

    Award Amount: $50,000

    Duration: One Year

  • Autoimmune Liver Diseases Pilot Research Award
    End: December 4, 2018

    The purpose of this one year, $20,000 award is to provide supplementary funding during the pilot phase of basic, translational or clinical research projects in autoimmune liver disease (e.g. autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis) in preparation for future grant applications by the recipient. Projects should address focused research questions pertaining to the pathogenesis, diagnosis, management or outcome of autoimmune liver diseases in children and adults.

    Program: American Association for the Study of Liver Disease

    Award Amount: $20,000

    Duration: one year

  • AASLD Pilot Research Award
    End: December 4, 2018

    The American Association for the Study of Liver Disease (AASLD) Foundation Pilot Research Award supports highly innovative research ideas that have a clear potential to produce high-impact results, but have little or no preliminary data to successfully compete for funding from other sources.

    Program: The American Association for the Study of Liver Disease Foundation

    Award Amount: $50,000

    Duration: one year

  • Columbia University Medical Center Diabetes Research Center Pilot Feasibility Grants
    End: December 10, 2018

     The Columbia Diabetes Research Center (DRC) announces the availability of Pilot and Feasibility grants to support diabetes-related research at Columbia University. Letter of Intend deadline: October 1, 2017.

    Program: Columbia University Medical Center

    Award Amount: Up to $50,000

    Duration: 1-2 years

  • UCLA CURE: Digestive Diseases Research Center CURE/CTSI Pilot and Feasibility Grant
    Start: August 20, 2015      End: December 15, 2018

    The CURE: Digestive Diseases Research Center (CURE: DDRC) and the UCLA Clinical and Translational Science Institute (CTSI) invite applications (new or second year renewal) for the 2017 academic year. Funding will be available for high quality and innovative research in the biology, function and diseases of the digestive system, which is of relevance to the overall CURE Research Program, with special emphasis on receptor and signal transduction mechanisms, brain-gut interactions, gastrointestinal and pancreatic physiology and inflammation, and mechanisms underlying diseases of the digestive system. Proposed projects should lead to peer-reviewed extramural funding such as NIH, VA or related agency research grants in which PFS awardees serve as Principal Investigators. Letter of Intent: September 25, 2017. Eligibility: Applicants must have a UCLA appointment (post-doc or beyond) by the time of the award.

    Program: UCLA CURE Digestive Diseases Research Center; UCLA Clinical and Translational Science Institute

    Award Amount: $20,000 to $35,000

    Duration: One Year

  • Boston University Alzheimer’s Disease Center Pilot Grant Program
    Start: July 1, 2015      End: January 11, 2019

    The Boston University Alzheimer’s Disease Center (BU ADC) is soliciting  proposals for pilot and feasibility Studies. New proposals or initiatives for biomedical, epidemiological behavioral, legal, ethical, health systems or other research in Alzheimer’s disease are encouraged. Two NIH funded proposals for $25,000 in direct costs for one-year non-renewable studies will be awarded. The Pilot Grant funding mechanism is intended to support new investigators from other fields eager to bring their research expertise to bear on Alzheimer’s disease, as well as feasibility testing of innovative drug and management approaches. Pilot study support is not intended for large undertakings by established investigators, or to enhance ongoing research projects, which are already funded.

    Program: Boston University

    Award Amount: $25,000

    Duration: One Year

  • Harvard University Digestive Disease Center Pilot and Feasibility Program
    End: January 14, 2019

    The HDDC is focused on the study of epithelial cell function and mucosal biology in inflammation, host defense, and cancer of the gastrointestinal tract and related mucosal surfaces. Pilot & Feasibility projects will be considered for support if they relate directly or indirectly to this mission. Letter of Intent due: November 20, 2017

    Program: Harvard University Digestive Disease Center

    Award Amount: $25,000

    Duration: One Year

  • The Michigan George M. O'Brien Kidney Translational Core Center Pilot/Feasibility Study Grant Program
    End: 11:59pm January 14, 2019

    The Michigan George M. O'Brien Kidney Translational Core Center (MKTCC) Pilot and Feasibility Grant Program provides funds to promote research initiatives by new and established investigators in the area of kidney disease. The goal of the program is to enable kidney researchers to generate preliminary data sufficient for successful application for major research funding from national funding agencies. Particularly encouraged are applications from junior investigators and investigators external to the renal community who have training and expertise that can be applied to the study of kidney disease. Eligibility: New investigators without current or past NIH support as a principal investigator, and whose current or previous support from other sources has been modest; Established investigators with limited previous kidney research experience who wish to apply their expertise to a problem in this area; and Established renal investigators who propose testing innovative ideas that represent a clear departure from their ongoing research directions. It is anticipated that the majority of the recipients of grant funding will be from the first category.

    Program: The Michigan George M. O'Brien Kidney Translational Core Center (MKTCC)

    Award Amount: $40,000

    Duration: one year

  • Washington University in St. Louis Center for Diabetes Translation Research Pilot and Feasibility Program
    End: February 1, 2019

    The purpose of the Pilot and Feasibility Program (PFP) of the CDTR is to foster innovative and transformative research designed to eliminate disparities in diabetes. The PFP focuses on type II translational research in diabetes defined as translating interventions with demonstrated efficacy into real-world healthcare settings, communities, and populations at-risk for health disparities. The PFP provides initial research support over limited time periods to eligible investigators exploring the feasibility of ideas or concepts related to the CDTR mission. 

    Program: Washington University in St. Louis Center for Diabetes Translation Research

    Award Amount: up to $5,000 (6-month small project); up to $25,000 (one-year project)

    Duration: 6 month or 1 year

  • Einstein-Sinai Diabetes Research Center Pilot and Feasibility Study Program
    End: February 1, 2019

     The Pilot & Feasibility Study Program provides initial support for new investigators, for established investigators to explore new directions, and to enable the ES-DRC to attract scientists from other disciplines to diabetes research. The Pilot and Feasibility (P&F) Study Program is a vital component of the ES-DRC and has successfully promoted numerous new research endeavors in diabetes-related areas. This program constitutes a key interface with the Einstein, Mount Sinai and academic community at large, and serves as a major attraction in the recruitment process. Over the past 37 years the DRTC has funded 113 feasibility studies from a pool of 449 applications. Pilot and Feasibility funds enable investigators to generate preliminary data to provide the basis for seeking extramural funding for their projects.

    Program: Einstein-Sinai Diabetes Research Center

    Award Amount: Up to $50,000

    Duration: 1-2 years

  • University of Chicago Diabetes Research and Training Center Pilot and Feasibility Program
    Start: October 15, 2015      End: February 1, 2019

    The Pilot and Feasibility (P and F) programs at the University of Chicago DRTC support new initiatives in diabetes related biomedical, epidemiological or behavioral research. The program is designed to provide limited support to develop preliminary data sufficient for funding of a research grant application or to test an innovative hypothesis which might have important implications or yield significant results for diabetes related research. Eligible investigators should hold a PhD, MD or MD/PhD degree and have a full time appointment at a research university or medical center in the Chicagoland area.  Postdoctoral and MD Fellows are not eligible to appy, while faculty of paranthetical rank are eligible to apply.  Applicants include new investigators without current or past NIH support as principal investigators, establish grant supported investigators who have not previously worked in diabetes related areas, or established investigators in diabetes related areas with a proposal for testing the feasibility of a new or innovative idea that is diabetes related and represents a clear and distinct departure from his/her ongoing research interests. The P and F programs at the University of Chicago provide a mechanism to foster the broad participation of investigators at various levels within the academic community and with highly varied training and experience in diabetes related research. Eligibility: University of Chicago Faculty

    Program: University of Chicago Diabetes Research and Training Center

    Award Amount: $40,000

    Duration: One Year

  • Northwestern University Feinberg School of Medicine Cognitive Neurology and Alzheimer’s Disease Center Pilot Project Grant Proposal Opportunity
    Start: December 1, 2015      End: February 1, 2019

    The proposed research project must be relevant to clinical or basic research on Alzheimer’s disease, other dementias or cognitive aging. Frontotemporal degeneration, primary progressive aphasia and unusually successful brain aging are additional areas of emphasis. Proposals that are based on human subjects of the Northwestern Alzheimer’s Disease Center or its tissue resources (DNA, fixed brain, frozen brain) will be given priority. Eligibility: The principal investigator must hold a faculty appointment, or be a postdoctoral fellow at North- western University.

    Program: Northwestern University Feinberg School of Medicine Cognitive Neurology and Alzheimer’s Disease Center

    Award Amount: $35,000

    Duration: One Year

  • Vanderbilt Diabetes Research & Training Center Grant
    Start: July 1, 2015      End: February 4, 2019

    An individual must be a member of the Vanderbilt or Meharry faculty (Instructor or above) and must fit within NIH Guidelines for eligibility. P&F support is targeted to any investigator, who has not previously received at DRTC P&F award, new or established, from other fields willing to bring their research expertise to diabetes-relevant research, for investigators currently in the diabetes area whose proposed research would constitute a totally new direction, and for clinical and basic researchers who propose a joint research project. DRTC P&F grants are intended to provide support for studies that allow an investigator to develop preliminary data sufficient to prepare an application for independent research support through conventional granting mechanisms. An investigator is eligible for DRTC P&F support only once. Eligibility: An individual must be a member of the Vanderbilt or Meharry faculty (Instructor or above) and must fit within NIH Guidelines for eligibility.

    Program: Vanderbilt Diabetes Research & Training Center

    Award Amount: N/A

    Duration: One Year

  • University of Pennsylvania Institute on Aging and Alzheimer’s Disease Core Center Pilot Study
    Start: November 20, 2015      End: February 4, 2019

    The University of Pennsylvania Institute on Aging (IOA) and Alzheimer’s Disease Core Center (ADCC) will fund up to six (6) one-year multidisciplinary pilot grants in the 2015-2016 academic year to support biomedical, epidemiological, behavioral or health services research, as well as basic science, clinical or psychosocial research. Two of the pilots, funded by Penn’s ADCC, will focus on Alzheimer’s disease (AD) and related neurodegenerative disorders as well as healthy brain aging. The remaining pilots, supported by funding from the Perelman School of Medicine at Penn (PSOM) to the IOA, will focus on aging and aging-related diseases as well as healthy aging. Eligibility: The Principal Investigator (PI) for each of these pilots must be a member of the University of Pennsylvania fulltime faculty from any of its 12 schools.

    Program: University of Pennsylvania Institute on Aging and Alzheimer’s Disease Core Center

    Award Amount: $50,000

    Duration: One Year

  • Vanderbilt Diabetes Center Discovery Program Grant
    Start: November 21, 2016      End: February 4, 2019

    An individual must be a member of the Vanderbilt or Meharry faculty (Instructor or above) and must fit within NIH Guidelines for eligibility. This P&F support is targeted to any investigator, new or established, proposing to utilize the VICB High-Throughput Screening Facility, BioVU, or the Vanderbilt Mass Spectrometry Research Center Cores to launch new research programs in drug, gene, or biomarker discovery related to diabetes, obesity, or the complications thereof. DRTC P&F grants are intended to provide support for studies that allow an investigator to develop preliminary data sufficient to prepare an application for independent research support through conventional granting mechanisms. This DRTC P&F grant mechanism is intended to support one year of research, although a second year of funding is possible through competitive application. Eligibility: An individual must be a member of the Vanderbilt or Meharry faculty (Instructor or above) and must fit within NIH Guidelines for eligibility.

    Program: Vanderbilt Diabetes Center

    Award: N/A

    Duration: One Year

  • Vanderbilt Digestive Disease Research Center Pilot Project
    Start: January 5, 2015      End: February 7, 2019

    The Pilot and Feasibility Project Program (P/F) is designed to provide Vanderbilt investigators the opportunity to explore nascent, meritorious hypotheses related to digestive diseases with the ultimate goal being acquisition of external funding. The Vanderbilt Digestive Disease Research Center (VDDRC) plans to fund pilot projects annually. Awards will be made for 1-2 years in duration. Letter of Intent deadline: January 9, 2018.

    Program: Vanderbilt Digestive Disease Research Center

    Award Amount: $25,000

    Duration: 1-2 year

  • Joslin Diabetes Center Pilot and Feasibility Studies
    End: February 15, 2019

     As part of the NIH grant that supports Joslin Diabetes Center’s Diabetes and Research Center (DRC), the Pilot & Feasibility (P&F) Program offers funding each year for two studies in the areas of type 1 diabetes, type 2 diabetes or their complications. The P&F awards may be from basic, translational or clinical perspectives.  The goal of the P&F Program is to encourage research on diabetes and its complications by two target groups: young diabetes researchers who recently became independent and have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction. Letter of Intent: January 4, 2019

    Program: Joslin Diabetes Center

    Award Amount: $50,000

    Duration: 1-2 years

  • Environmental Health Sciences Research Center (EHSRC) Pilot Grant Program
    Start: December 15, 2015      End: February 15, 2019

    The EHSRC Pilot Grant Program seeks innovative, environmental health-related research proposals from University of Iowa researchers eligible to apply for K or R01 grants from NIH. Proposals for laboratory and/or field research will be accepted. Areas of EHSRC interest for funding include, but are not limited to, the following: Studies of susceptibility to environmentally induced disease (gene/environment interactions), Nanotoxicology, Environmental risk factors for disease, Fundamental biology with environmental relevance, Environmental and mammalian toxicology, Occupational and environmental medicine, Assessment of exposures to environmental agents, and Environmental remediation and control.All University of Iowa researchers eligible for apply for K or R01 grants from NIH are invited to apply. This specifically includes Post-doctoral Fellows, Post-doctoral Scholars, Faculty (all ranks) and Research Scientists, Research Engineers, Associate Research Scientists, Associate Research Engineers, Other categories of individuals; students and staff may not be investigators but may be designated to receive salary support and should be listed in the budget. Eligibility: Post-doctoral Fellows, Post-doctoral Scholars, Faculty (all ranks) and Research Scientists, Research Engineers, Associate Research Scientists, Associate Research Engineers at the University of Iowa.

    Program: Environmental Health Sciences Research Center

    Award Amount: $40,000

    Duration: One Year

  • University of Alabama at Birmingham Nutrition Obesity Research Center Pilot and Feasibility Program
    Start: March 1, 2016      End: February 18, 2019

    Pilot/Feasibility Studies provide 1-2 years of support to enable eligible investigators to explore the feasibility of nutrition or obesity-related concept and acquire sufficient data to pursue extramural funding opportunities. Pilot/Feasibility funding generally supports full-time faculty members who are new investigators (usually below the rank of Associate Professor) and without current or past NIH research project support. Less frequently, we fun established investigator for whom the topics of nutrition and obesity represent a substantial departure from their current work. Solicitation of applications occurs annually, with the intent to support 6-7 on-goin Pilot/Feasibility Study projects at a level of up to $35,000/year. Eligibility:  full-time UAB faculty members who are new investigators without current or past NIH research project support (those below the rank of Associate Professor); established investigators with no previous work in nutrition or obesity research; or established investigators in nutrition/obesity with a proposal to test an innovative idea representing a significant departure from ongoing research interests. P/F awards may be made to post-doctoral fellows. However, generally, post-doctoral fellows will only be competitive when such individuals are preparing to transition to a faculty slot at UAB.

    Program: University of Alabama at Birmingham Nutrition Obesity Research Center

    Amount: $35,000

    Duration: 1 year

  • The Johns Hopkins University - University of Maryland (JHU-UMD) Diabetes Research Center (DRC) Pilot and Feasibility Program
    End: February 22, 2019

     The Pilot and Feasibility (P and F) Program, directed by Dr. Sally Radovick, of the JHU-UMD Diabetes Research Center (DRC) is seeking applications to support new initiatives in diabetes-related biomedical, epidemiological or behavioral research. The JHU-UMD DRC is an NIH-funded joint-venture between the Johns Hopkins University, University of Maryland and Howard University School of Medicine. It is composed of Cores that are designed to support research in diabetes and related endocrine and metabolic diseases. The JHU-UMD DRC is one of seven national centers. Application deadline will be the last Friday of the following February.

    Program: Johns Hopkins Medicine - University of Maryland Diabetes Research Center

    Award Amount: Up to $50,000

    Duration: 1 year

  • Georgia Center for Diabetes Translation Research: Pilot & Feasibility Pilot Award Program
    End: February 28, 2019

    Emory University, in partnership with Georgia Tech and Morehouse School of Medicine, has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to establish the Georgia Center for Diabetes Translation Research (Georgia CDTR). The mission of the center is to facilitate and grow diabetes translation research at Emory, its partner institutions, and regionally. In alignment with this mission, this Request for Pilot and Feasibility Applications is a solicitation for pilot proposals that focus on Type II translation research in diabetes care and prevention. Type II (T2) translation is defined as research focused on translating interventions/approaches that have clearly demonstrated efficacy into real world health care settings, communities, and populations at risk with an emphasis on reach, sustainability, and potential for widespread implementation.Investigators are encouraged to propose studies that align with the focus of one or more Research Cores within the Center:  Disparities, Design and Evaluation, and Engagement and Behavior Change. The Disparities Core addresses the roles of demographic, life-span, race/ethnicity, immigration, and diabetes co-morbidities (e.g., co-existent CVD, HIV or cognitive and psychological disorders) on diabetes rates, treatment, and outcomes. The Design and Evaluation Core focuses on models of delivering effective preventive and health care services, including innovative use of technologies, workforce development, and/or metrics and evaluation. The Engagement and Behavior Change Core focuses on enhancing adoption and maintenance of prevention and care interventions for diabetes among those in need and incorporates expertise and resources from the fields of behavioral sciences, screening, and community-based participatory research. In addition, proposals are encouraged, although not required, to focus on the following target populations: minorities, the elderly, youth, and persons with HIV. Eligibility: Faculty researchers from Emory University, Morehouse School of Medicine, the Atlanta Veterans’ Affairs System, Georgia Institute of Technology and Georgia State University are eligible to apply for pilot and feasibility funding if they fit in one of the following categories: (1) New investigators without current or past NIH research support as a principal investigator or program director (priority) (2)Established investigators with no previous work in T2 translation diabetes research (3)Established investigators who propose testing innovative ideas that represent a clear departure from their ongoing research interests

    Program: Georgia Center for Diabetes Translation Research

    Award Amount: up to $30,000

    Duration: 1 year

  • MMPC MICROMouse Program
    Start: September 1, 2015      End: March 1, 2019

    MICROMouse will fund high impact technology-, physiology-, or biology-based projects conceived through interaction with, or between MMPCs. Proposal objectives should take clear advantage of collaborations with MMPCs to address questions that would be otherwise difficult to answer. Objectives of the MICROMmouse initiative encompasses pilot and feasibility projects for the development of new mouse phenotyping tests, as well as research-driven projects that investigate biology and physiology of disease.The aim of the MICROMouse program is to promote the development of mouse phenotyping technology and encourage collaborative relationships between the MMPC and its users. These are 1 year awards intended to fund the development of research opportunities that may arise during the course of a service provided by the MMPC or to expand on research interests common to a MMPC user and a MMPC principal investigator. These awards cannot be used simply to purchase services from an MMPC. There is no formal deadline associated with MICROMouse applications, but applications will be reviewed quarterly (March 1, June 1, September 1, December 1) and so should be submitted accordingly. A letter of intent with a brief (2-3 sentences) description of the proposed project must be sent to Dr. Richard McIndoe at rmcindoe@gru.edu at least two weeks prior to submission of an application. 

    Program: MMPC

    Award Amount: $75,000

    Duration: 1 year

  • Pennington Biomedical Research Center Nutrition Obesity Research Center Pilot and Feasibility Program
    Start: October 14, 2016      End: March 25, 2019

    The major objective of this program is to provide research support to test innovative hypotheses from individuals or multidisciplinary teams involving nutrition/obesity-related research and other pilot studies related to the function of the NORC. Applicants should note that the theme of the PBRC NUTRITION OBESITY RESEARCH CENTER is “Nutrition, Obesity and Metabolic Health throughout the Lifespan.” In accord with our NORC award from NIDDK-NIH, we will be developing collaborative research teams focusing on three critical periods of the life cycle: Maternal/Infant nutritional status and metabolic consequences; Pediatric and adulthood obesity and metabolic health; Nutritional status at older age to preserve physical and cognitive functionality. Letter of Intent deadline: February 4, 2019.

    Program: PBRC Nutrition Obesity Research Center

    Award: $34,000 - $85,000

    Duration: 1 year

  • Chicago Center for Diabetes Translation Research Pilot and Feasibility Grants Program
    End: April 1, 2019

    Chicago Center for Diabetes Translation Research Pilot and Feasibility Grants Program aimed at: 1) Attracting more junior investigators of the faculty into the area of type II diabetes-related translational research; 2) Allowing more established investigators who are not currently engaged in type II diabetes translational research to extend their investigations into this important area; or 3) Permitting any investigator to test a novel hypothesis of relevance to diabetes type II translational research which might not yet meet NIH requirements for R01 or R18 funding. Applicants must be CCDTR members to apply.

    Program: Chicago Center for Diabetes Translation Research

    Award Amount: up to $25,000

    Duration: 1 year

  • Michigan Center for Diabetes Translational Research Pilot/Feasibility Grant Program
    End: April 1, 2019

    The purpose of this Pilot and Feasibility Grant Program is to promote research in diabetes by new and established investigators.Eligibility: Faculty at the University of Michigan and the University of North Carolina at Chapel Hill. New investigators beginning careers in diabetes-related research, established investigators who have not previously worked in diabetes-related research but who wish to focus their expertise on diabetes, or established diabetes investigators who propose innovative research in diabetes that represents a clear departure from their ongoing research.

    Program: Michigan Center for Diabetes Translational Research

    Award Amount: $50,000

    Duration: one year

  • Nutrition Obesity Research Center at Harvard
    Start: January 1, 2015      End: April 1, 2019

    The overall goal of the Pilot and Feasibility Project (PFP) is to stimulate innovative research relevant to nutrition, metabolism, or obesity. We hope that this program will be a mechanism through the Center to encourage basic investigators to extend their studies into nutrition/obesity, often in collaboration with investigators in the Center and directly focused on clinical/translational problems. PFP recipients will receive preferential access to the Core facilities. Eligible applicants fall into one of 3 categories: (1) Early career investigators in nutrition, metabolism, or obesity; (2) established investigators new to the field of nutrition, metabolism or obesity research; or (3) established investigators in the field looking for funding for a new direction in nutrition, metabolism or obesity research.  Investigators from any Harvard institution are eligible to apply.  Per NIH rules, fellows are not allowed to be PI of these grants, but final-year fellows may apply if the grant would be awarded after completion of their fellowship.  Applicants are encouraged to take advantage of our Core laboratories. New this year:  For applications with topics relevant to both obesity and type 2 diabetes, a joint P&F award totaling $60,000 over 1 year, with opportunity for renewal for a 2nd year, may be awarded by the NORCH and the BADERC (Boston Area Diabetes and Endocrinology Research Center).  Please indicate in your application if you would like to be considered for this joint award.

    Program: Nutrition Obesity Research Center at Harvard

    Amount: up to $30,000

    Duration: 1 - 2 year

  • University of California, San Diego (UCSD) Center for AIDS Research International Pilot Grants Available for HIV/AIDS Research
    Start: August 14, 2015      End: April 1, 2019

    The UC San Diego Center for AIDS Research (CFAR) International Core offers Pilot grants to investigators in seven countries. Preference will be given to supporting projects based in Mexico and Mozambique, and funds are also available to support meritorious projects in Brazil, India, Kenya, South Africa, and Zimbabwe. Our focus countries offer the potential for long-term collaboration between investigators at UC San Diego and one or more academic or government entities. The list of eligible countries is reviewed annually by the International Core Advisory Board.The maximum award is US$40,000 in direct costs for one year. From 2006-2016, the Core awarded 43 Pilot grants representing more than $1.5 million in funding. Applications must adhere to several criteria and must undergo a rigorous, objective review process.Pilot grant recipients gain financial support for their studies and discounts on many CFAR resources. In return, the International Core expects grant recipients to successfully apply for subsequent grant funding and to publish manuscripts related to their CFAR-supported research. Continued NIAID funding of the International Core will be primarily determined by the subsequent scientific productivity of pilot grant recipients. As of 2016, a total of 86  manuscripts have been published related to Pilot grants, and more than $39 million awarded in subsequent grants. To be eligible for our Pilot grants, you must possess a doctoral-level degree, and you must be affiliated with an academic or government institution in one of our seven focus countries. Visit website for more details.

    Program: University of California, San Diego (UCSD) Center for AIDS Research

    Award Amount: $40,000

    Duration: 1 year

  • Integrated Islet Distribution Program (IIDP) Islet Award Initiative
    Start: January 18, 2018      End: April 1, 2019

    The IIDP Islet Award Initiative is intended to advance research in human islet biology by facilitating the ability of researchers to access human islets for high impact and novel research studies. The number of IIDP Islet Awards funded under this initiative will be determined in any single year based on available resources. the new IIDP Islet Award Initiative (IIDP-IAI), replacing the previous IIDP Pilot Program, which will provide human islets to investigators without the need of a paid subscription. This new program is being supported by generous contributions from JDRF. Application Due Date(s): Quarterly - Jan 7, April 1, August 1 of each calendar year

    Program: Integrated Islet Distribution Program

    Award Amount: Undetermined. The number of IIDP Islet Awards funded under this initiative will be determined in any single year based on available resources.

    Duration: 2 years

X

Are you sure you want to delete that component?